Bellinato Francesco, Gisondi Paolo, Marzano Angelo Valerio, Piaserico Stefano, De Simone Clara, Damiani Giovanni, Argenziano Giuseppe, Venturini Marina, Dapavo Paolo, Costanzo Antonio, Megna Matteo, Prignano Francesca, Burlando Martina, Satolli Francesca, Carugno Andrea, Pezzolo Elena, Romanelli Marco, Cuccia Aldo, Girolomoni Giampiero
Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126 Verona, Italy.
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Vaccines (Basel). 2023 Mar 27;11(4):740. doi: 10.3390/vaccines11040740.
Generalized pustular psoriasis (GPP) is a rare, severe inflammatory skin disease characterized by recurrent episodes of flares. Characteristics of patients experiencing a flare are hardly described in a real-life setting. The aim of the study is to investigate the clinical characteristics of patients experiencing a flare of GPP.
Multicenter retrospective observational study on consecutive patients experiencing a flare of GPP between 2018 and 2022. Disease severity and quality of life were assessed by Generalized Pustular Psoriasis Area, Body Surface Area (BSA), and Severity Index (GPPASI), and Dermatology life quality index (DLQI) questionnaire, respectively. Visual analogue scale (VAS) of itch and pain, triggers, complications, comorbidities, pharmacological therapies, and outcome were collected.
A total of 66 patients, 45 (68.2%) females, mean age 58.1 ± 14.9 years, were included. The GPPASI, BSA, and DLQI were 22.9 ± 13.5 (mean ± standard deviation), 47.9 ± 29.1, and 21.0 ± 5.0, respectively. The VAS of itch and pain were 6.2 ± 3.3 and 6.2 ± 3.0, respectively. Fever (>38 °C) and leukocytosis (WBC > 12 × 10/L) were found in 26 (39.4%) and 39 (59.1%) patients, respectively. Precipitating triggers were identified in 24 (36.3%) and included infections (15.9%), drugs (10.6%), stressful life events (7.6%), and corticosteroids withdrawal (3.0%). Fourteen (21.2%) patients were hospitalized because of complications including infections in 9 (13.6%) leading to death in one case and hepatitis in 3 (4.5%).
GPP flares can be severe and cause severe pain and itch with significant impact on the quality of life. In about one-third of patients the flare may have a persistent course and, with complications, lead to hospitalization.
泛发性脓疱型银屑病(GPP)是一种罕见的严重炎症性皮肤病,其特征为反复发作。在现实生活环境中,很少描述银屑病发作患者的特征。本研究的目的是调查GPP发作患者的临床特征。
对2018年至2022年间连续发作GPP的患者进行多中心回顾性观察研究。分别通过泛发性脓疱型银屑病面积、体表面积(BSA)和严重程度指数(GPPASI)以及皮肤病生活质量指数(DLQI)问卷评估疾病严重程度和生活质量。收集瘙痒和疼痛的视觉模拟量表(VAS)、诱发因素、并发症、合并症、药物治疗及结局。
共纳入66例患者,其中45例(68.2%)为女性,平均年龄58.1±14.9岁。GPPASI、BSA和DLQI分别为22.9±13.5(平均值±标准差)、47.9±29.1和21.0±5.0。瘙痒和疼痛的VAS分别为6.2±3.3和6.2±3.0。分别有26例(39.4%)和39例(59.1%)患者出现发热(>38°C)和白细胞增多(白细胞>12×10/L)。24例(36.3%)患者确定了诱发因素,包括感染(15.9%)、药物(10.6%)、应激性生活事件(7.6%)和糖皮质激素撤药(3.0%)。14例(21.2%)患者因并发症住院,其中9例(13.6%)为感染,1例死亡,3例(4.5%)为肝炎。
GPP发作可能很严重,会导致严重疼痛和瘙痒,对生活质量有重大影响。约三分之一的患者发作可能呈持续性病程,并伴有并发症,导致住院治疗。